Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

Saved in:
Bibliographic Details
Title: Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.
Authors: Farace, F.1,2, Mathiot, C.3,4, Brandely, M.5, Tursz, T.1, Dorval, T.3, Pouillart, P.3, Triebel, F., Hercend, T.1,2, Fridman, W. H.3,4
Source: Clinical & Experimental Immunology. Nov1990, Vol. 82 Issue 2, p194-199. 6p.
Database: Academic Search Ultimate
Description
ISSN:00099104